跳至主要内容
临床试验/NCT07380139
NCT07380139Enrolling By Invitation1 期

Dexamethasone Versus Dexmedetomidine as Adjuvant to Bupivacaine in Sphenopalatine Ganglion Block as Post-operative Analgesia in Rhinoplasty Surgeries

Ain Shams University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年2月1日最近更新:
干预措施

试验速览

阶段
1 期
状态
Enrolling By Invitation
入组人数
90
试验地点
1
主要终点
The time to the first request of analgesia

研究概览

简要总结

This study will test the effect of adding dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in sphenopalatine ganglion block used for pain after rhinoplasty

详细描述

Preoperative settings:

Preoperative evaluation of full medical history will be taken, examination will be done, and routine preoperative investigations will be done to all patients including complete blood picture and coagulation profile.

The patient will be fasting for at least 8 hours preoperatively

Intraoperative settings:

General anesthesia technique:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65 years.
  • Sex: of either sex.
  • American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
  • Scheduled for rhinoplasty surgeries under general anaesthesia.

排除标准

  • Declining to give written informed consent.
  • History of allergy to the medications used in the study.
  • Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
  • Psychiatric disorder.

研究组 & 干预措施

Group BD

Active Comparator

Group BD: will receive bupivacaine 0.25% (3ml) + dexamethasone (4mg), total volume 5ml by adding normal saline

干预措施: Dexamethasone (Drug)

Group B

Active Comparator

Group B (control group): will receive bupivacaine 0.25% (3ml) + normal saline, total volume (5 ml).

干预措施: Bubpivacaine (Drug)

Group BDX

Active Comparator

Group BDX: will receive bupivacaine 0.25% (3ml) + dexmedetomidine (1 mic/kg), total volume 5ml by adding normal saline.

干预措施: Dexamedomedine (Drug)

结局指标

主要结局

The time to the first request of analgesia

时间窗: 9 months

The time interval between the onset of the local infiltration done at the end of the operation and the first request to postoperative analgesia

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验